16 Pulmonary Hypertension Clinical Trials in Commack, NY (2026)

Q: How do I join a clinical trial in Commack?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Commack research site will contact you.

Recruiting Pulmonary Hypertension Studies in Commack

NCT00582621Recruiting

Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders

The purpose of this study is to better understand the genetic causes of Hodgkin's disease (a kind of lymphoma) and non-Hodgkin's lymphoma, as well as multiple myeloma, leukemia, and related diseases. ...

Commack, NY500 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07029217Recruiting

A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas

The researchers are doing this study to find out whether a very low dose of radiation therapy (VLDRT) is an effective treatment for people with follicular lymphoma (FL) or marginal zone lymphoma (MZL)...

Commack, NYPHASE3375 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT03618550Recruiting

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

The purpose of this study is to test any good and bad effects of the study drug, pembrolizumab, in combination with GVD in the treatment of Hodgkin lymphoma....

Commack, NYPHASE2257 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05389293Recruiting

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

The purpose of this study is to find out if mosunetuzumab is an effective treatment in people with follicular lymphoma that was recently diagnosed and have not yet received any treatments for their di...

Commack, NYPHASE2152 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT02974647Recruiting

Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

The purpose of this study is to test any good and bad effects of the study drug called ruxolitinib. Ruxolitinib works by blocking a protein called JAK. JAK works along with another protein called STAT...

Commack, NYPHASE283 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06377566Recruiting

A Study of BV-AVD in People With Bulky Hodgkin Lymphoma

The purpose of this study is to test whether BV-AVD is an effective treatment in people with early stage, bulky Hodgkin lymphoma that was recently diagnosed and who have not yet received any treatment...

Commack, NYPHASE271 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05010005Recruiting

A Study of Ruxolitinib and Duvelisib in People With Lymphoma

This study will test the safety of ruxolitinib, given at one dose that does not change, and duvelisib, given at different doses, to find out what effects, if any, the study treatment has on people wit...

Commack, NYPHASE170 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06736613Recruiting

A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

The purpose of this study is to find out how many people with B-cell lymphoma who are at high risk for central nervous system/CNS relapse test positive for cerebral spinal fluid/CSF ctDNA but test neg...

Commack, NYPHASE250 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06123338Recruiting

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

The purpose of this study to find out whether adding trastuzumab and pembrolizumab to standard chemotherapy is an effective treatment for resectable HER2+ esophagogastric cancer....

Commack, NYPHASE249 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06765317Recruiting

A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma

The researchers are doing this study to find out if the study treatment is an effective treatment that causes few or mild side effects in people with diffuse large B-cell lymphoma (DLBCL), high-grade ...

Commack, NYPHASE242 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07449208Recruiting

Registry Study of People Who Are Having an Esophagectomy and Are at High Risk of Anastomotic Leak

The main purpose of this study is to look at how often anastomotic leaks happen in participants who are at high risk of these leaks and are eligible to receive gastric preconditioning by percutaneous ...

Commack, NY40 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07001384Recruiting

A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)

The researchers are doing this study to see if alectinib in combination with duvelisib is a safe and effective time-limited treatment for people with relapsed or refractory ALK+ anaplastic large cell ...

Commack, NYPHASE130 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05307939Recruiting

A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

This study will look at whether monitoring HPV ctDNA levels is an effective way to detect cancer relapse risk in people with HPV-OPC. All participants will have recently had surgery to treat their dis...

Commack, NYPHASE230 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT04872543Recruiting

A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST)

The purpose of this study is to see whether the study drug ASTX727 is an effective treatment for people who have MPNST with a PCR2 mutation. ASTX727 is a combination of two drugs (cedazuridine and de...

Commack, NYPHASE225 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07249528Recruiting

A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy

The purpose of this study is to collect voice recordings and nervous system (neurologic) assessments from people with non-Hodgkin lymphoma (NHL) or multiple myeloma (MM) who are receiving standard tre...

Commack, NY20 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05296304Recruiting

A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides

The researchers are doing this study to test the safety of combining bexarotene with TSEB radiotherapy in people who have a common form of CTCL called mycosis fungoides (MF). Bexarotene is a form of ...

Commack, NYPHASE120 participantsMemorial Sloan Kettering Cancer Center

View Study Details

About Pulmonary Hypertension Clinical Trials in Commack

Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.

There are currently 16 pulmonary hypertension clinical trials recruiting participants in Commack, NY. These studies are seeking a combined 1,814 participants. Research is being sponsored by Memorial Sloan Kettering Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Hypertension Clinical Trials in Commack — FAQ

Are there pulmonary hypertension clinical trials in Commack?

Yes, there are 16 pulmonary hypertension clinical trials currently recruiting in Commack, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Commack?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Commack research site will contact you about next steps.

Are clinical trials in Commack free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Commack studies also compensate for your time and travel.

What pulmonary hypertension treatments are being tested?

The 16 active trials in Commack are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.

Data updated October 16, 2026 from ClinicalTrials.gov